BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 29216926)

  • 1. Pro-inflammatory adjuvant properties of pigment-grade titanium dioxide particles are augmented by a genotype that potentiates interleukin 1β processing.
    Riedle S; Pele LC; Otter DE; Hewitt RE; Singh H; Roy NC; Powell JJ
    Part Fibre Toxicol; 2017 Dec; 14(1):51. PubMed ID: 29216926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct roles for Nod2 protein and autocrine interleukin-1beta in muramyl dipeptide-induced mitogen-activated protein kinase activation and cytokine secretion in human macrophages.
    Hedl M; Abraham C
    J Biol Chem; 2011 Jul; 286(30):26440-9. PubMed ID: 21659536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts.
    Yang S; Takahashi N; Yamashita T; Sato N; Takahashi M; Mogi M; Uematsu T; Kobayashi Y; Nakamichi Y; Takeda K; Akira S; Takada H; Udagawa N; Furusawa K
    J Immunol; 2005 Aug; 175(3):1956-64. PubMed ID: 16034140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NOD2/CARD15 genotype influences MDP-induced cytokine release and basal IL-12p40 levels in primary isolated peripheral blood monocytes.
    Beynon V; Cotofana S; Brand S; Lohse P; Mair A; Wagner S; Mussack T; Ochsenkühn T; Folwaczny M; Folwaczny C; Glas J; Török HP
    Inflamm Bowel Dis; 2008 Aug; 14(8):1033-40. PubMed ID: 18383179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muramyldipeptide augments the actions of lipopolysaccharide in mice by stimulating macrophages to produce pro-IL-1β and by down-regulation of the suppressor of cytokine signaling 1 (SOCS1).
    Shikama Y; Kuroishi T; Nagai Y; Iwakura Y; Shimauchi H; Takada H; Sugawara S; Endo Y
    Innate Immun; 2011 Feb; 17(1):3-15. PubMed ID: 19897531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engagement of NOD2 has a dual effect on proIL-1beta mRNA transcription and secretion of bioactive IL-1beta.
    Ferwerda G; Kramer M; de Jong D; Piccini A; Joosten LA; Devesaginer I; Girardin SE; Adema GJ; van der Meer JW; Kullberg BJ; Rubartelli A; Netea MG
    Eur J Immunol; 2008 Jan; 38(1):184-91. PubMed ID: 18157816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A NOD2-NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and muramyl dipeptide.
    Hsu LC; Ali SR; McGillivray S; Tseng PH; Mariathasan S; Humke EW; Eckmann L; Powell JJ; Nizet V; Dixit VM; Karin M
    Proc Natl Acad Sci U S A; 2008 Jun; 105(22):7803-8. PubMed ID: 18511561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pannexin-1-mediated intracellular delivery of muramyl dipeptide induces caspase-1 activation via cryopyrin/NLRP3 independently of Nod2.
    Marina-García N; Franchi L; Kim YG; Miller D; McDonald C; Boons GJ; Núñez G
    J Immunol; 2008 Mar; 180(6):4050-7. PubMed ID: 18322214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Species-specific engagement of human nucleotide oligomerization domain 2 (NOD)2 and Toll-like receptor (TLR) signalling upon intracellular bacterial infection: role of Crohn's associated NOD2 gene variants.
    Salem M; Seidelin JB; Eickhardt S; Alhede M; Rogler G; Nielsen OH
    Clin Exp Immunol; 2015 Mar; 179(3):426-34. PubMed ID: 25335775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of lipopolysaccharide-induced cytokine gene expression in mouse bone marrow-derived macrophages by muramyl dipeptide.
    Le Contel C; Temime N; Charron DJ; Parant MA
    J Immunol; 1993 May; 150(10):4541-9. PubMed ID: 8482846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations.
    Li J; Moran T; Swanson E; Julian C; Harris J; Bonen DK; Hedl M; Nicolae DL; Abraham C; Cho JH
    Hum Mol Genet; 2004 Aug; 13(16):1715-25. PubMed ID: 15198989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDP-induced interleukin-1beta processing requires Nod2 and CIAS1/NALP3.
    Pan Q; Mathison J; Fearns C; Kravchenko VV; Da Silva Correia J; Hoffman HM; Kobayashi KS; Bertin J; Grant EP; Coyle AJ; Sutterwala FS; Ogura Y; Flavell RA; Ulevitch RJ
    J Leukoc Biol; 2007 Jul; 82(1):177-83. PubMed ID: 17403772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal responses to specific NOD1-activating peptidoglycan agonists in the presence of the NOD2 frameshift and other mutations in Crohn's disease.
    van Heel DA; Hunt KA; Ghosh S; Hervé M; Playford RJ
    Eur J Immunol; 2006 Jun; 36(6):1629-35. PubMed ID: 16637007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing.
    Maeda S; Hsu LC; Liu H; Bankston LA; Iimura M; Kagnoff MF; Eckmann L; Karin M
    Science; 2005 Feb; 307(5710):734-8. PubMed ID: 15692052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic stimulation of Nod2 mediates tolerance to bacterial products.
    Hedl M; Li J; Cho JH; Abraham C
    Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19440-5. PubMed ID: 18032608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NOD2 transgenic mice exhibit enhanced MDP-mediated down-regulation of TLR2 responses and resistance to colitis induction.
    Yang Z; Fuss IJ; Watanabe T; Asano N; Davey MP; Rosenbaum JT; Strober W; Kitani A
    Gastroenterology; 2007 Nov; 133(5):1510-21. PubMed ID: 17915219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The frameshift mutation in Nod2 results in unresponsiveness not only to Nod2- but also Nod1-activating peptidoglycan agonists.
    Netea MG; Ferwerda G; de Jong DJ; Werts C; Boneca IG; Jéhanno M; Van Der Meer JW; Mengin-Lecreulx D; Sansonetti PJ; Philpott DJ; Dharancy S; Girardin SE
    J Biol Chem; 2005 Oct; 280(43):35859-67. PubMed ID: 16115863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nod2 downregulates TLR2/1 mediated IL1β gene expression in mouse peritoneal macrophages.
    Dahiya Y; Pandey RK; Sodhi A
    PLoS One; 2011; 6(11):e27828. PubMed ID: 22114704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDP-Induced selective tolerance to TLR4 ligands: impairment in NOD2 mutant Crohn's disease patients.
    Cantó E; Moga E; Ricart E; Garcia-Bosch O; Garcia-Planella E; Juarez C; Vidal S
    Inflamm Bowel Dis; 2009 Nov; 15(11):1686-96. PubMed ID: 19572373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell-derived soluble glycoprotein GPIbα mediates PGE
    Liu F; Endo Y; Romantseva T; Wu WW; Akue A; Shen RF; Golding H; Zaitseva M
    Sci Signal; 2019 Oct; 12(602):. PubMed ID: 31594856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.